Stay updated on Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study record shows a new revision version (v3.5.4) replacing the previous v3.5.3. This indicates a backend or documentation update, and no study details appear to be altered.
    Difference
    0.1%
    Check dated 2026-05-15T23:52:26.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The site footer revision number was updated from v3.5.2 to v3.5.3, indicating a website/version refresh without changing the trial details.
    Difference
    0.1%
    Check dated 2026-04-24T16:52:21.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:38:26.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0, replacing v3.4.3. This appears to be an internal version update with no changes to the study content.
    Difference
    0.1%
    Check dated 2026-03-19T22:14:14.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T19:45:18.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The revision label was updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:54:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.